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IntroductIon
Hypertension is the main, though modifiable, risk fac-
tor for cardiovascular diseases such as coronary heart 
disease, heart and renal failure, stroke and peripheral 
vascular disease. Cardiovascular diseases contribute 
to one third of deaths worldwide. The World Health 
Organization (WHO) estimates that worldwide preva-
lence of arterial hypertension (AH) is more than one 
billion people, it is implicated in 7.1 million prema-
ture deaths and in 4.5% of the disease load1. 
Adopting a healthy lifestyle is essential for the pre-
vention and treatment of hypertension. The changes in 
lifestyle should include reducing weight, adoption of 
nutritional models, such as DASH (Dietary Approach-
es to Stop Hypertension) and the Mediterranean diet, 
reducing dietary sodium, increasing physical activity, 
reducing alcohol consumption and the immediate ces-
sation of smoking2. 
The DASH diet is a balanced diet plan that incor-
porates the dietary recommendations into a healthy 
diet plan and contains more dark vegetables, orange 
vegetables, legumes, fruits, grains and low fat dairy 
products and minimum quantity of saturated fat, add-
ed sugar and extra calories. Central role in shaping the 
DASH diet plays a selection of foods rich in vitamins 
and minerals, which give a few calories (Nutrient-
Dense Foods)3. 
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Mediterranean diet is the dietary pattern developed 
in countries where olive tree is cultivated, during the 
decades 1950-19604. The main difference between the 
DASH diet and the Mediterranean diet is the high con-
tent of olive oil in the Mediterranean diet. The three 
main groups that determine the beneficial effects of 
olive oil is oleic acid, polyphenols and squelene5. In 
relation to blood pressure, the exact mechanism of ac-
tion of olive oil in managing hypertension is not fully 
understood. Proposed mechanisms are olive oil acting 
as a calcium channel blocker, mimicking the action of 
the drug verapamili6, improving endothelial function, 
reducing vascular tone and changing the composition 
of fatty acids and phospholipids in aorta7. 
The Mediterranean diet appears to have beneficial 
effects on lipoprotein levels, vasodilation, on cardio-
vascular disease, arthritis, cancer and psychological 
functioning. Nevertheless, the impact on primary pre-
vention is still under investigation. In recent years the 
vast majority of studies considered individual dietary 
components. People, though, consume combinations 
of foods. The present study tries to prioritize the Medi-
terranean diet among major components of nutrition, 
such as sodium, potassium, fats and carbohydrates. 
PAtIentS And MethodS 
During the biennium 2004-2006, 300 adult patients 
with a history of primary hypertension were esti-
mated at Hypertension Clinic of the General Hospi-
tal of Halkidiki. The control group consisted of adult 
patients of the outpatient Orthopedic Clinic of the 
General Hospital of Halkidiki, who had no history of 
hypertension. 
Recording of the data and other parameters was 
accomplished by using a questionnaire during in-
terviews. The questionnaire included questions on 
general demographics, physical activity at work and 
recreation, nutrition, the consumption of alcoholic 
beverages, smoking habits, family history of hyper-
tension and taking antihypertensive medication. 
Blood pressure was measured at both upper arms 
while sited, and the higher value was recorded. There 
were three measurements within 5 minutes apart, after 
the patient had rested for 30 minutes and the mean 
value was recorded. For the measurement of anthropo-
metric parameters a flexible measuring tape was used 
to measure waist circumference at the level of umbi-
licus (the nearest 0,1 cm). The weight was measured 
to the nearest 0,1 kg. Patients, during the measure-
ment of weight, were wearing light clothing (without 
shoes). Also, measurement of height was to the near-
est 0,5 cm without shoes. Based on the measurement 
of height and weight, body-mass index (Body Mass 
Index-BMI) was calculated, using the formula BMI = 
Weight (Kg) / Height (cm)2. 
Regarding diet habits a thorough recording of the 
intake of specific foods and rating based on a six-figu-
re scale followed8 (never / rarely, 1-3times/month, 1-2 
times/week, 3-4times/week, 4-5times/week, daily). 
The reference period was the previous year. The in-
formation gathered was used to calculate the daily 
energy intake (kcal/day), the daily consumption of 
simple carbohydrates (monosaccharides and disac-
charides in grams / day) and the Keys score9 [Keys 
score = 1,35 (2SFA %-PUFA%) +1,5 (C1/2), where 
SFA stands for saturated fatty acids (in% share of total 
energy intake), PUFA for the intake of polyunsatu-
rated fatty acids (in% share of total energy intake), 
and C for total cholesterol intake (in mg/1000kcal)]. 
The higher the Keys score the greater relative intake 
of saturated fatty acids and cholesterol and the lower 
intake of polyunsaturated fatty acids. The dietary fiber 
(in gr/day) and dietary sodium, potassium, calcium 
and magnesium (in mg/day) were, also, calculated. 
The choice for calculating these nutrients was due to 
their special reference in dietary guidelines10. 
For a more complete assessment of the nutritional 
characteristics of the sample, apart from the calcula-
tion and evaluation of individual dietary components, 
we attempted to approach the evaluation of a com-
prehensive standard diet and specifically the degree 
of approximation of the sample’s diet to the Mediter-
ranean dietary pattern. To this end the Mediterranean 
diet score was calculated as follows (Mediterranean 
Diet score-MediDietScore, range 0-55)11 . Based on 
the principles of the Mediterranean diet the following 
10 food groups were assessed: unprocessed cereals 
and related products, fruits and nuts, vegetables, ol-
ive oil, low fat dairy, fish, poultry, potatoes, legumes, 
red meat and eggs, as well as alcohol drinking. For 
foods that are part of the Mediterranean diet (cereals 
processed foods and related products, fruits and nuts, 
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vegetables, olive oil, low fat dairy products, fish, po-
tatoes and legumes) a score of 0, when the subjects 
did not report any or rare consumption, 1 when the 
food had been consumed 1-3 times a month, 2 when 
consumed 1-2 times per week, 3 when consumed 3-4 
times per week, 4 when consumed 5-6 times a week 
and 5 when consumed daily, was given. For foods 
not included in the Mediterranean diet (poultry, red 
meat and eggs) a reverse score was established (rang-
ing between 0 for daily consumption to 5 for rare or 
no consumption). Especially for alcohol, a score of 5 
was applied for those who drunk 1-2 drinks per day, 
a score of 0 for consuming > 7 glasses of alcohol per 
day and a score of 1 to 4,for drinking 6-7, 4-5, 0,and 
3 drinks per day respectively. The higher the Medi-
DietScore, the closer the adherence to Mediterranean 
dietary pattern.
For the quantification of smoking the number of 
pack-years was calculated by multiplying the years 
of smoking to the number of packages (20 cigarettes) 
been smoked daily11. In the multivariable model, we 
included in the category “smokers” those patients who 
had smoked even one cigarette per day in the last year 
or had quit within the last year, while all other indi-
viduals were considered as non-smokers.
For estimating those with the metabolic syndrome, 
the coexistence of three of the following five conditions 
was necessary: 1. Waist circumference ≥ 94cm Men / 
≥ 80cm women, 2. Serum triglycerides ≥ 150mg%, 3. 
Serum HDL cholesterol ≤ 40mg% male / ≤ 50mg% 
female, 4. Fasting glucose ≥ 110mg%, 5. Arterial hy-
pertension or antihypertensive medication12.
To assess physical activity during both work and 
recreation, the metabolic equivalents (Mets) were cal-
culated based on questions on physical activity during 
work, on the type of transportation and on sporting 
and non-sporting activities. The metabolic equivalent 
is expressed as the ratio of metabolic rate (and hence 
the rate of energy consumption) during a specific 
physical activity in relation to the metabolic rate at 
rest, defined by convention in 3,5 ml O2/kg. min, or 
1 kcal (4.184 kJ)/kg.hr. By convention 1 Met is the 
metabolic equivalent required during a quiet rest. The 
values of physical activities were assessed as multi-
ples of 1 Met ranging from 0.9 (during sleep) to 18 
(during running by 17,5 km/h). To assess physical 
activity during work, each light work was rated by 3 
Mets, a moderate one by 4,5 Mets, a heavy one by 6 
Mets and a very severe work by 10 Mets. In the study 
every activity above the level of calm was evaluated 
by multiplying the hours of physical activity with the 
intensity of each activity, while individuals who had 
not reported any activity were recorded as producing 
0 Met13. 
StAtIStIcAl AnAlySIS
The regularity of distribution of all continuous vari-
ables was performed with Kolmogorov-Smirnov 
test (for samples> 50 individuals) and Shapiro-Wilk 
test(for samples <50 individuals).
Continuous variables that were normally distribu-
ted were described by the mean + / - standard devia-
tion, and those that were not normally distributed by 
the median and the maximum and minimum values. 
The categorical variables were described as absolute 
and relative frequencies. Relations between categori-
cal variables were tested by x2 test. The comparisons 
between continuous variables normally distributed in 
the survey sample were done using Student’s t-test. For 
non normally distributed variables the Mann-Whitney 
test was used. The odds for an individual to develop 
hypertension were assessed by calculating οdds ratios 
and corresponding confidence intervals (95%) through 
a binomial logistic regression model14.
Interactions between age (a factor with clinical and 
statistical significance in all groups) and other factors 
(covariates) were tested and were retained in the final 
model, when significant. 
Hosmer-Lemeshow statistical test was used to esti-
mate the goodness-of-fit of the model. Then to further 
assess the effect of dietary factors on the occurrence 
of hypertension a core model was formed consisting 
of key determinants of hypertension (age, gender, edu-
cation [in years of study] , physical activity, smoking 
habit, systolic and diastolic measurements of blood 
pressure, presence of metabolic syndrome and family 
history of arterial hypertension). The nutritional fac-
tors were, subsequently, added to the core model and 
x2 was calculated for each variable. The higher the x2 
value, the greater the role of the nutritional factor to 
the occurrence of hypertension. Quantitative variables 
were correlated with Spearman’s correlation coeffi-
cient (rs).
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All reported p values are based on two-sided tests 
and compared to a 5% significance level. For all the 
calculations the statistical package SPSS 16 was used 
(Statistical Package for Social Sciences, SPSS Inc, 
Chicago, IL, USA). 
reSultS
Table 1 shows the characteristics of the study popu-
lation and the univariable statistical comparisons be-
tween hypertensive patients and patients in the control 
group. 
As expected, the values of systolic and dia-
stolic pressure were significantly increased in the 
group of hypertensive patients compared with con-
trols (p < 0,001 for both comparisons), whereas age 
was greater in the group of hypertensive patients 
(p < 0,001) and the distribution of sex did not ap-
pear to differ in the two groups (p = 0,907). The body 
mass index (BMI) was positively correlated with 
the appearance of blood pressure being in average 5 
points higher in the group of hypertensive patients. 
Of the demographic factors, place of residence, edu-
cational level, gainful employment and residence size 
were related significantly to the appearance of arterial 
hypertension, whereas marital status did not appear to 
be related to a significant extent. In detail, residing in 
a rural area increases the odds of hypertension by 1.6 
times (OR [Odds Ratio] = 1,58, CI [confidence inter-
val] 95% = 1,093-2,430), the completion of compul-
sory studies reduces the odds by 78,8% (OR = 0,212, 
95% CI = 0,123-0,363), unemployment increases the 
odds by 4.4 times (OR = 4,39, CI95% +2,81-7,021) 
and living in a house with less than two rooms in-
creases the odds by 1.5 times (OR = 1,48, CI95% = 
1,056-2,334). 
The energy expenditure during physical activi-
ty, both at work and at leisure time, seems to have a 
positive impact on the prevention of blood pressure 
table 1. Characteristics of hypertensive patients and control group in the study population.
Study population (n = 400)
Hypertensive  
patients (n = 300)
Control group  
(n = 100)
P
Age (years) 64+/-12 59+/-9 < 0.001
Sex (male) % 41,7 41 0.907
SBP1 (mmHg) 148+/-19 117+/-13 < 0.001
DBP2 (mmHg) 84+/-12 75+/-10 < 0.001
ΒΜΙ (%) 30+/-4 25+/-3 < 0.001
Marital status (married) (%) 76 83 0.145
Residence area (urban) (%) 38 65 < 0.001
Duration of education (years) 8+/-5 12+/-4 < 0.001
Paid work (yes) (%) 24 73 < 0.001
Size of residence (>2 rooms) (%) 47 68 < 0.001
Metabolic syndrome (yes) (%) 74 30 0.01
Physical activity ΜΕΤs 8+/-4 10+/-7 0.03
Smoking (%) 43 25 0.01
Family history (%) 81 62 < 0.001
Continuous variables are expressed as mean +/- standard deviation, categorical variables as percentage (%). 1Systolic 
Blood 1Pressure, 2Diastolic Blood Pressure.
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(p = 0,03). The coexistence of risk factors compris-
ing the metabolic syndrome was present at 63% of the 
total sample and 74% of hypertensive patients. The 
existence of the metabolic syndrome was related to a 
significant extent with the appearance of blood pres-
sure (p = 0,01). Smoking appeared to increase the 
odds of hypertension (p = 0,01). More specifically, 
for people who smoked, the number of cigarettes con-
sumed daily (expressed as pack-years) was associ-
ated with the occurrence of hypertension [median 25 
pack-years for the hypertensive group (min = 0/max = 
117) and 16 for the control group (min = 0/max = 17), 
(p = 0,012)]. Smoking increased the odds of developing 
hypertension by 1,4 times for every 5 pack-years in-
crease in cigarettes consumption (OR = 1,378, CI95% 
= 1,071-1,762, p < 0,001). On the other hand both the 
quality of tobacco (blond, black, mix), (p = 0,246), 
and the type of cigarettes (regular, light, ultra-light), 
(p = 0,771) were not found to be associated with the 
appearance of arterial hypertension (AH). Still, family 
history of hypertension appeared to increase the odds 
of hypertension (p < 0,001). 
With regard to medication, the number of phar-
maceutical antihypertensive drugs for each patient is 
shown in Figure 1. More specifically, 73.2% of the 
sample of hypertensives regulating blood pressure 
(BP) received less than two drugs, while the corre-
sponding figure for those who did not regulate BP 
was 51.6%. The rest received more than two drugs 
(p = 0,005). In relation to the type of drugs adminis-
tered 70.6% of the sample took diuretics (p = 0,009), 
58,0% inhibitors of angiotensin II (p = 0,38), 47,6% 
calcium channel blockers (p = 0,940), 45,1% b-block-
ers (p = 0,061) and 26.6% angiotensin converting en-
zyme inhibitors (p = 0,699). Regarding the class of 
medicines in relation to groups of patients regulating 
and not regulating their blood pressure, no statisti-
cal significance was found (p
diouritika
 = 0.081, p
AT1
 = 
0,122, p
CCB 
= 0,096, p 
b-blockers 
= 0,091, p 
ACEI 
= 0.086). 
 Regarding the nutritional characteristics of the sam-
ple (Table 2), those that maintain a significant rela-
tionship and contribute to the onset of hypertension 
were increased energy intake (p < 0,001), saturated fat 
(p < 0,001), simple carbohydrates (p <0,001) and di-
etary sodium (p = 0.001). Protective effect on the on-
set of hypertension appeared to have increased dietary 
potassium (p < 0,001), calcium (p = 0,029) and mag-
nesium (p < 0,001) intake, as well as the adherence to 
the Mediterranean dietary pattern (p < 0,001). 
The odds of an individual developing arterial hy-
table 2. Nutritional characteristics of hypertensive patients and control group in the study population.
Study population (n = 400)
Hypertensive  
patients (n = 300)
Control group  
(n = 100)
p
TEI1 (kcal) 2446+/-595 1948+/-408 < 0.001
Keys score 39+/-8 32+/-4 < 0.001
Simple carbohydrates (g) 125+/-41 108+/-29 < 0.001
Dietary fiber (g) 37+/-8 38+/-9 0.614
Dietary Sodium (mg) 1988+/-690 1167+/-339 < 0.001
Dietary Potassium (mg) 5127+/-884 5582+/-1296 0.001
Dietary Calcium (mg) 1383+/-329 1466+/-398 0.029
Dietary Magnesium (mg) 424+/-99 511+/-64 < 0.001
MediDietScore 32+/-6 41+/-3 < 0.001
Continuous variables are expressed as mean +/- standard deviation and categorical variables as percentage (%).
1Total Energy Intake
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pertension in relation to key factors (core) and dietary 
factors are shown in Table 3. Univariably, all factors, 
other than sex and nutritional dietary fiber were sig-
nificantly associated with the occurrence of hyperten-
sion. More specifically, the odds of a person develop-
ing hypertension increased 1.2 times for every 5 years 
increase in age, 2.3 times if the person smoked, 6.6 
times if the metabolic syndrome coexisted, nearly 4 
times if family history of AH coexisted, 1.2 times per 
100kcal increase in calorie intake, 2.1 times for eve-
ry 5 units increase of Keys score (intake of saturated 
fatty acids), 2.1 times for every 50g increase in simple 
carbohydrate intake and 4.8 times for every 500mg 
increase in dietary sodium intake. 
On the other hand, the odds of developing hyper-
tension diminishes by 34% for every 5 Mets increase 
in physical activity, by 19.6% for every year increase 
in studying duration, by 82.2% for every 5 units ad-
herence to Mediterranean diet, by 19.9% for every 
500mg increase in potassium intake, by 29.8% for 
every 500mg increase in dietary calcium intake and 
by 82.2% for every 150mg increase in dietary mag-
nesium intake. 
For a more thorough analysis regarding the influ-
ence of diet on the occurrence of hypertension, the 
odds of developing the disease for total energy intake, 
for lipids (Keys score), simple carbohydrates, fiber, 
sodium, potassium, calcium and magnesium intake, 
and for the overall pattern of Mediterranean diet were 
estimated taking into account the gender, the age, the 
physical activity, smoking, the metabolic syndrome, 
the baseline systolic and diastolic blood pressure, the 
duration of education and the family history of arterial 
hypertension. The results are shown in Table 4. 
The element that was closer related to the appear-
ance of AH was the component of the Mediterranean 
diet (OR = 0,694, x2 = 42,37, p < 0,001), and was 
followed hierarchically by sodium intake (OR = 5,61, 
x2 = 38,153, p < 0,001), magnesium intake (OR = 
0,182, x2 = 29,819, p < 0,001), total calorie intake 
((OR = 1,227, x2 = 15,357, p < 0,001) and fiber intake 
(OR = 0,484, x2 = 8,944, p = 0,003). Finally, the po-
tassium intake tended towards statistical significance 
(OR = 0,845, x2 = 3,367, p = 0,066).
dIScuSSIon 
Hypertension is internationally recognized as an im-
portant factor in cardiovascular disease and overall 
mortality15. Despite the growing recognition of hyper-
tension by physicians and their patients only 34% of 
patients taking some measures to treat hypertension 
achieve their gouls16. In the sample of the survey, 36% 
Figure 1. Number of administered antihypertensive drugs in the groups of patients controlling hypertension and not 
achieving control.
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of hypertensive patients achieved BP regulation, a rate 
consistent with previous data from Greece17.
Regarding the importance of nutrition in prevent-
ing and regulating blood pressure, although in the 
lite rature exist studies that support the role of DASH 
or the Mediterranean diet, as well as studies like IN-
TERMAP study18, which refer to individual food in-
gredients, as far as we know no study correlates in a 
hierarchical model a diet model with the main macro-
and micro-dietary components that appear to affect 
hypertension. 
The importance of the Mediterranean diet has been 
widely known since the 1970s, after the publication 
of the Seven Seas Study19. The Mediterranean diet 
seems to have a beneficial effect on lipoprotein lev-
els, vasodilation, antioxidant capacity, on cardiovas-
cular disease, arthritis, cancer, body composition and 
psychological function20. Nevertheless, the impact on 
primary prevention is still under investigation. In re-
cent years the vast majority of studies considered in-
dividual dietary components. People, though, do not 
consume food ingredients. They eat meals with vari-
ous combinations of foods and therefore a more holis-
tic approach to diet seems to be more appropriate. To 
assess the diet pattern, the Mediterranean diet score 
was selected (MediDietScore), which has the greatest 
predictive value for hypertension21. 
table 3. Univariable binary logistic regression models that estimate the effect of basic and dietary factors on the occurrence 
of blood hypertension.
FActorS odds ratio (or)
Confidence Intervals  
(95%cI) p-value
Maximum Minimum 0,906
Sex (male/female) 0,970 0,610 1,112 < 0,001
Age (5 years) 1,201 1,087 1,328 < 0,001
Physical activity (5 Mets) 0,666 0,533 0,832 0,001
Smoking (yes/no) 2,293 1,381 3,802 < 0,001
SBP1 (5mmHg) 1,775 1,563 2,016 < 0,001
DBP2 (5 mmHg) 1,437 1,281 1,611 < 0,001
Metabolic Syndrome (yes/no) 6,641 4,030 10,944 < 0,001
Duration of education (years) 0,804 0,761 0,850 < 0,001
Family history (yes/no) 3,921 2,314 6,622 < 0,001
MediDietScore (5 units) 0,178 0,119 0,265 < 0,001
TEI3 (100kcal) 1,205 1,146 1,272 < 0,001
Keys Score (5 μονάδες) 2,082 1,680 2,580 < 0,001
Dietary simple carbohydrates (50g) 1,761 1,297 2,391 < 0,001
Dietary fiber (10g) 0,774 0,595 1,008 0,057
Dietary Sodium (500mg) 4,818 3,366 6,897 < 0,001
Dietary Potassium (500mg) 0,801 0,714 0,899 < 0,001
Dietary Calcium (500mg) 0,702 0,501 0,982 0,039
Dietary Magnesium (150mg) 0,178 0,109 0,289 < 0,001
1Systolic Blood Pressure, 2Diastolic Blood Pressure, 3Total Energy Intake.
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Other dietary patterns, such as the diet DASH, 
have been proposed. The main difference of the Medi-
terranean diet is its high content in olive oil, which is 
rich in omega-3 fatty acids and alpha-linolenic acid, 
the beneficial effects of which are shown in various 
studies22,23,24. 
Other researchers have used different scales for 
assessing the Mediterranean diet. Both Trichopoulou 
and Martinez propose two 9-point rating scales25,26, to 
show the inverse relationship between Mediterranean 
diet and cardiovascular risk. Small scales, neverthe-
less, may overestimate the reduction in risk, fail to 
appreciate cases close to their limits and, also, fail to 
highlight the inherent characteristics of a model or a 
behavior. For all these reasons a 55-point rating scale 
was selected.
The percentage of patients following the Medi-
terranean diet is not considered satisfactory for the 
whole sample (62% exceed the limit of 26.6, which is 
marginal for hypertension27), and differs significant-
ly in the group of hypertensive patients and control 
group (18 % of the hypertensive group does not reach 
the threshold, while in the control group all subjects 
are above the threshold, p < 0,001). Within the group 
of hypertensive patients 60% of patients regulating 
blood pressure and 41 % of those who fail exceed the 
limit of 26.6% , but in this case there is no statisti-
cal significance (p = 0,163). Data from the U.S. by 
Mellen et al indicate that only 19.4% of Americans 
follow the DASH diet, percentage decreased by 7.3% 
over the previous year28. Moreover, the study found 
that for every 5 point greater adherence to Mediter-
ranean diet leads to 30.6% reduction in the likelihood 
of developing hypertension. These results are similar, 
but greater than those (26%) given by Panagiotakos et 
al29 in more urban areas. This difference may be due 
to the fact that in this study the most sensitive 55-point 
rating scale was used.
Despite the large number of studies on the effect 
of dietary sodium in the treatment of blood pressure, 
the relationship between sodium and the prevention 
of blood pressure remains controversial30. Neverthe-
less, He and Mac Gregor indicate that increased intake 
of sodium may have direct negative consequences re-
gardless of the increase in blood pressure, such as in-
creased risk for stroke, obesity, through the consump-
tion of soft drinks, kidney disease, osteoporosis and 
gastric cancer31 , while the reduction of excess dietary 
sodium improves the response to antihypertensive 
drugs32. Cook et al stress that the reduction in sodium 
table 4. Multivariate binary logistic regression models assessing the effect of dietary factors on development 
of hypertension.
ModelS or Confidence Intervals
 (cI 95%)
X2 P value
Minimum Maximum
Μοdel 1: MediDietScore  (5 units) 0,694 0,596 0,808 42,376 <  0,001
Μοdel 2: TEI1 (100kcal) 1,227 1,095 1,373 15,357 <  0,001
Μοdel 3: Keys Score (5 μονάδες) 1,172 0,785 1,751 0,634 0,426
Μοdel 4: Dietary simple carbohydrates 
(50g)
1,435 0,767 2,683 1,281 0,281
Μοdel 5: Dietary fiber (10g) 0,484 0,292 0,802 8,944 0,003
Μοdel 6: Dietary Sodium(500mg) 5,61 2,61 12,043 38,153 <  0,001
Μοdel 7: Dietary Potassium (500mg) 0,845 0,702 1,016 3,367 0,066
Μοdel 8: Dietary Calcium (500mg) 0,761 0,402 1,44 0,715 0,397
Μοdel 9: Dietary Magnesium (150mg) 0,182 0,087 0,379 29,819 <  0,001
1Total Energy Intake, OR: Odds Ratio, CI: Confidence Interval.
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consumption by the change in lifestyle has medium 
effect on blood pressure regulation33. However, in the 
Trials of Hypertension Prevention Study a reduction 
by 25% in cardiovascular risk was found, despite a 
small decrease in blood pressure34. This led Mohan 
and Campel to emphasize that the cooperation of lo-
cal governments and the food industry is the least ex-
pensive measure for the prevention of hypertension35. 
The increase of endovascular volume and the increase 
of endogenous Na (+), K (+) ATPases appear to be 
the pathogenic mechanisms by which sodium affects 
blood pressure30. 
These mechanisms, apart from sodium, seem to be 
affected by the intake of potassium36. Both DASH and 
the Mediterranean diet are based on factors rich in po-
tassium, such as fruits and vegetables. Nevertheless, 
studies from the Netherlands37 and Sweden38 are un-
able to substantiate the action of potassium. These dif-
ferences might be due to different populations under 
study (the first study was conducted among geriatric 
patients and the second among male smokers). In the 
present study, potassium appears to have a tendency to 
prevent the development of hypertension (p = 0,066). 
The study was conducted in Northern Greece where 
most participants exceeded the recommended, by the 
DASH diet, limit for potassium intake (78% of the to-
tal sample). 
The results in the present study indicate that the 
total energy consumption has the greatest correla-
tion coefficient with body mass index (rs = 0,578, 
p < 0,001). It is generally accepted in the literature, 
that the reduction of energy consumption during life-
time is beneficial in the treatment of obesity, diabetes, 
hypertension and atherosclerosis, provided that the re-
duction of energy intake does not lead to a decrease of 
the intake of essential nutrients39. Nevertheless, Dirks 
and Leeuvenburgh indicate that reducing calories may 
lead to lower living standards, which limits the appli-
cation of reducing energy consumption40. 
In the multivariable model dietary magnesium 
seems to be a statistically significant in preventing 
AH. More specifically, for every 150mg increase in 
dietary magnesium, the odds of developing hyperten-
sion are reduced by 82.8%. Joffres and colleagues have 
highlighted the strong negative relationship between 
dietary magnesium and blood pressure41 and a meta-
analysis of 20 randomized trials showed a decrease of 
1.5 times for each increment of dietary magnesium of 
483mg42. Nevertheless, data from NHANES study43 
and a systematic review of 12 randomized clinical 
trials failed to show the relationship between magne-
sium and hypertension control44. 
A statistically significant inverse relationship be-
tween hypertension and consumption of fiber was, 
also, shown. A 10g increase in fiber consumption 
leads to a reduction in the likelihood of hyperten-
sion in 51,6% (p = 0,03). The intake of dietary fiber 
is quite satisfactory. 82.2% of hypertensive patients 
and 94.9% in the control group consume more dietary 
fiber than it is recommended by DASH diet (30g dai-
ly), (p = 0,003). Other studies, however, recommend 
14g/1000kcal energy45. In the group of hypertensive 
patients 83.8% of patients regulating blood pressure 
and 82.1% of patients failing to regulate it consume 
more dietary fiber than 30g daily (p = 0,691).
In the literature, the effect of dietary calcium on 
blood pressure is quite discussed. Low dietary cal-
cium intake appears to increase the intracellular 
concentration of calcium, leading to increased 1,25-
dihydroxyvitamin D3 and parathyroid hormone le-
vels, leading to calcium entry in smooth muscle blood 
vessels and thus to vasoconstriction46. Miller et al, 
in particular, stress the importance of the nutritional 
origin of adequate calcium intake47. Main source of 
calcium in the Western world is milk and dairy pro-
ducts. Dairy products have a positive effect on blood 
pressure beyond calcium, as they, also, provide mag-
nesium, potassium and peptides with activity similar 
to ACE inhibitors48. In the present study a statistically 
significant relationship between dietary calcium and 
the occurrence of arterial hypertension was found. 
Furthermore, the calcium intake was low in both the 
hypertensive group, and the control group (28.7% and 
32.5% respectively, p = 0,055). Factors affecting low 
calcium intake are the replacement of milk consump-
tion with soft drinks consumption and dining out47. 
The formation of the ideal diet for preventing hy-
pertension is still under investigation, and so is its con-
tent in carbohydrate and fat. Consumption of simple 
sugars, such as sucrose and fructose, is implicated in 
the increased incidence of insulin resistance and meta-
bolic syndrome. In particular, Rayssiguier et al49 report 
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the effect of fructose in the inflammatory response. 
Fructose is a disaccharide, which is important because 
of its use in soft drinks. Although, many modern nu-
tritional guidelines for the prevention of hypertension 
support the consumption of more carbohydrates than 
fat50, Phillips et al note that eating more fat leads to 
improved endothelial function and consequently to 
cardiovascular protection51. Both Sharma et al52 and 
Mazaffarian53 propose a diet balanced in polyunsatu-
rated fats and complex carbohydrate for the control of 
metabolic diseases. In this study, a statistically signifi-
cant relationship between the consumption of simple 
carbohydrates and the development of arterial hyper-
tension was found.
Apart from seeking better diet recommendations 
for control of hypertension in the literature, a num-
ber of dietary antihypertensive agents and functional 
foods, like L-arginine and other active peptides54, 
chlorogenic acid, soy, omega-3 fatty acids22 and plant 
factors, such as alkaloids, flavonoids and terpenoids55 
are suggested. The effect of these factors remains to 
be proven.
Regarding the position of the model of the Medi-
terranean diet among other nutrients that are impor-
tant in the prevention and treatment of hypertension 
we found that the model of the Mediterranean diet had 
the leading role (x2 = 42,37, p < 0,001), when com-
pared with total energy intake and with the consump-
tion of other dietary factors. Still, for every 5 points 
greater adherence to Mediterranean diet the incidence 
of hypertension was reduced by 82.2%. 
In conclusion, lifestyle changes, particularly the 
adoption of a healthy diet model, like the mediterra-
nean diet is the main tool for preventing chronic dis-
eases such as hypertension. The mediterranean diet 
combines features such a reduction in saturated fats, 
salt, and total energy intake with the beneficial effects 
of olive oil. Furthermore, interventions, such as ex-
ercise increase, smoking cessation and limited alco-
hol consumption should not be underestimated. The 
change in life style will enable us to control, not only 
hypertension, but, also, diseases like coronary heart 
disease, cardiac and renal failure, stroke and periph-
eral vascular disease. 
ΠΕΡΙΛΗΨΗ: Σκοπός της μελέτης, η οποία αποτελεί μία μελέτη ασθενών μαρτύρων, είναι η διερεύνηση της επίδρασης του 
προτύπου της μεσογειακής διατροφής στην πρόληψη της αρτηριακής υπέρτασης και η ιεράρχησή του σε σχέση με μεμονω-
μένα διατροφικά στοιχεία, ανεξάρτητα άλλων παραγόντων εμφάνισης υπέρτασης. Τη διετία 2004-2006, εκτιμήθηκαν στο 
Υπερτασιολογικό Ιατρείο του Γενικού Νοσοκομείου Χαλκιδικής 300 ενήλικες ασθενείς με ιστορικό πρωτοπαθούς υπέρτασης 
και 100 ενήλικες ως ομάδα ελέγχου. Η καταγραφή των στοιχείων και παραμέτρων έγινε με τη χρήση ερωτηματολογίου κατά 
τη διάρκεια συνέντευξης. Το ερωτηματολόγιο περιελάμβανε ερωτήσεις σχετικές με τα γενικά δημογραφικά στοιχεία, τη 
φυσικής δραστηριότητα κατά την εργασία και την αναψυχή, με τη διατροφή, με την κατανάλωση αλκοολούχων ποτών, με 
τις καπνιστικές συνήθειες, το οικογενειακό ιστορικό υπέρτασης και τη λήψη φαρμακευτικής αγωγής. Ακολούθως, υπολογί-
στηκαν η συνολικά προσλαμβανόμενη ενέργεια, ο δείκτης Keys score, οι απλοί υδατάνθρακες, οι φυτικές ίνες, το νάτριο, 
το κάλιο, το ασβέστιο και το μαγνήσιο της διατροφής, καθώς και ο δείκτης Μεσογειακής διατροφής. Οι παράγοντες αυτοί 
ελέγχθηκαν μονοπαραγοντικά και πολυπαραγοντικά και βρέθηκε, ότι ο κυριότερος παράγοντας στην πρόληψη της αρτηρι-
ακής υπέρτασης είναι το πρότυπο της μεσογειακής διατροφής και ακολουθεί η διατροφική πρόσληψη νατρίου, μαγνησίου 
και η συνολικά προσλαμβανόμενη ενέργεια. Συμπεραίνεται, ότι η υιοθέτηση προτύπων διατροφής φαίνεται να υπερτερεί 
της τροποποίησης μεμονωμένων διατροφικών στοιχείων.
Λέξεις Κλειδιά: Υπέρταση, Μεσογειακή διατροφή, Πρόληψη, Τρόπος ζωής, Διατροφικά πρότυπα.
Ο ρόλος της Μεσογειακής διατροφής στην πρόληψη της αρτηριακής υπέρτασης  
σε σχέση με την εκτίμηση μεμονωμένων διατροφικών στοιχείων.
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Ηλίας Τυροδήμος, Μαλαματένια Αρβανιτίδου-Βαγιωνά
Εργαστήριο Υγιεινής Ιατρικής Σχολής Α.Π.Θ.
 Mediterranean Diet, Hypertension Prevention 33
  1. Βurt VL, Whelton P, Rocella CJ. Prevalence of hyper-
tension in the US adult population. Results from the 
Third National Health and Nutrition Examination Sur-
vey, 1988-1991. Hypertension 1995;25:305-18.
  2. U.S. Department of Health and Human Services. The 
Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure. NIH Publication No 04-5230 
2004.
  3. Padiyar A. Non pharmacologic management of hy-
pertension in the elderly. Clin Geriatr Med 2009; 
25:213-9.
  4. Panagiotakos DB, Pitsavos C, Skoumas Y, Stefanadis 
C. The association between food patterns and the met-
abolic syndrome using components analysis: the AT-
TICA study. J Am Diet Assoc 2007;107:979-87.
  5. Waterman E, Lockwood B. Active components and 
clinical applications of olive oil. Altern Med Rev 
2007; 12 331-342.
  6. Giliani AH, Khan AU, Shah AJ. Blood pressure lower-
ing effect of olive is mediated through calcium chan-
nel blockade. Int J Food sci Nutr 2005;56:613-620.
  7 .Ferrara LA, Raimondi AS, d΄Episcopo L. Olive oil 
and reduced need for antihypertensive medications. 
Arch Intern Med 2000;160:837-42.
  8. Psaltopoulou T, Naska A, Orfanos P, Trichopoulos 
D, Mountokalakis T, Trichopoulou A. Olive oil, the 
Mediterranean diet, and arterial blood pressure: the 
Greek European Prospective Investigation into Can-
cer and Nutrition( EPIC)study. Am J Clin Nutr 2004; 
80:1012-8.
  9. Cheng C, Graziani C, Diamond JJ. Validation of the 
dietary risk assessment food questionnaire against the 
keys score or saturated fat and cholesterol. J Nutr Educ 
Behav 2005;37:152-3.
10. U.S. Department of Health and Human Services and 
U.S. Department of Agriculture. Dietary guidelines for 
Americans, 2005. 6th Edition, Washington, DC: U.S. 
Goverment Printing Office.
11. Bernards CM, Twisk JW, Snel J, Van Mechelen W. Is 
calculating pack-years retrospectively a valid method 
to estimate life-time tobacco smoking? A comparison 
between prospectively calculated pack-years and ret-
rospectively calculated pack-years. Addiction 2001; 
96:1653-61.
12. Bruce KD, Hanson MA. The developmental origins, 
mechanisms, and implications of metabolic syndrome. 
J Nutr 2010.
13. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, 
Swartz AM, Strath SJ et al. Compendium of physical 
activities: an update of activity codes and MET inten-
sities. Med Sci Sports Exerc 2000;32: 98-504.
14. Μ. Αrvanitidou-Vagiona. Case-control studies. In: 
Social and Preventive Medicine. 1st ed. Thessaloniki: 
University Studio Press; 2009. p.55-62.
15. Brendan ME, Glynn RJ . Combination therapy vs 
monotherapy as initial treatment for stage 2 hyperten-
sion: A prespectified subgroup analysis of a commu-
nity-based, randomized, open-label trial. Clin Ther 
2008; 30:661-72.
16. Ezzati M, Lopez AD. Selected major risk factors and 
global and regional burden of disease. Lancet 2002; 
300:1347-1360.
17. Efstratopoulos AD. Prevalence, awareness, treat-
ment and control of hypertension in Hellas, Greece: 
the hypertension Study in General Practice in Hellas 
(HYPERTENSHELL) national study. Am J Hyperten 
2006;19:53-60.
18. Stamler J, Elliot P, Dyer AR, Kesteloot H, Liu K, 
Ueshima H et al. J Hum Hypertens 2003; 17:591-608.
19. Keys A, Menotti A, Karvonen MJ. The diet and the 
15-year death rate in the seven Countries Study. Am J 
Epidemiol 1986; 124:903-15.
20. Serra-majem L, Roman B, Estruch R. Scientific evi-
dence of interventions using the Mediterranean diet: a 
systematic review. Nutr Rev 2006; 64:S27-47.
21. Panagiotakos D, Pitsavos C, Arvaniti F, Stefanadis 
C. Adherence to Mediterranean food pattern predicts 
the prevalence of hypertension, hypercholesterolemia, 
diabetes and obesity, among healthy; the accuracy of 
the MedDietScore. Prev Med 2007; 44:335-40.
22. Riediger ND, Othman RA, Suh M, Moghadasian 
MH. A systematic review of the role of n-3 fatty ac-
ids in health and disease. J Am Diet Assoc 2009;109: 
668-79.
23. Barre DE. The role of consumption of alpha-linolenic, 
eicosapentaenoic and docosahexaenoic acids in hu-
man metabolic syndrome and type 2 diabetes-a mini 
review. J Oleo Sci 2007;56:319-25.
24. Bourre JM. Dietary omega-3 fatty acids for women. 
Biomed Pharmacother 2007;61:105-12.
25. Trichopoulou A, Costacou T, Bamia C, Trichopoulos 
D. Adherence to a Mediterranean diet and survival in a 
greek population. N Engl J Med 2003;348:2599-608.
26. Panagiotakos DB, Pitsavos C, Stefanadis C. Dietary 
patterns: a Mediterranean diet score and its relation to 
clinical and biological markers of cardiovascular dis-
ease risk. Nutr Metab Cardio Dis 2006;16:559-568.
27. Panagiotakos D, Pitsavos C, Arvaniti F, Stefanadis C. 
Adherence to Mediterranean food pattern predicts the 
prevalence of hypertension, hypercholesterolemia, di-
abetes and obesity, among healthy adults; the accuracy 
of the MedDietScore. Prev Med 2007;44:335-40.
reFerenceS
34 Aristotle University Medical Journal, Vol. 37, Issue 2, June 2010
28. Mellen PB, Gao SK, Vitolins MZ, Goff DC Jr. Deteri-
orating dietary habits among adults with hypertension: 
DASH accordance, NHANES 1988-1994 and 1999-
2004. Arch Intern Med. 2008 Feb 11;168:308-14.
29. Panagiotakos DB, Pitsavos CH, Chrysohoou C, Skou-
mas J, Papadimitriou L, Stefanadis C et al. Status and 
management of hypertension in Greece: role of the 
adaption of a Mediterranean diet: The ATTICA study. 
J Hypertens 2003;21:1483-9.
30. Haddy FJ. Role of dietary salt in hypertension. Life 
Sci 2006;79:1585-92.
31. He FJ, MacGregor GA. A comprehensive review on 
salt and health and current experience of worldwide 
salt reduction programmes. J Hum Hypertens 2009; 
23:363-84.
32. Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, 
Dell’Italia LJ. Effects of dietary sodium reduction on 
blood pressure in subjects with resistant hypertension: 
results from a randomized trial. Hypertension 2009; 
54:475-81.
33. Cook NR. Salt intake, blood pressure and clinical out-
comes. Curr Opin Nephrol Hypertens 2008; 17:310-4.
34.. Cook NR. Joint effects of sodium and potassium in-
take on subsequent cardiovascular disease: the Trials 
of Hypertension Prevention follow-up study. Arch In-
tern Med 2009;169:32-40.
35. Martinez-Gonzales MA, Fernadez-Jarne E, Serrano-
Martinez M, Wright M, Gomez-Garcia E. Develop-
ment of a short dietary intake questionnaire for the 
quantitative estimation of adherence to a cardiopro-
tective Mediterranean Diet. Eur J Clin Nutr 2004; 
58:1550-2.
36. Karpannen H, Karpannen P, Mervaala E. Why and 
how to implement sodium, potassium, calcium and 
magnesium changes in food items and diets? J Hum 
Hypertens 2005;3:10-9.
37. Geleijnse JM, Witteman JC, Stijnen T, Kloos MW, 
Hofman A, Grobbee DE. Sodium and potassium in-
take and risk of cardiovascular event and all-cause 
mortality: the Rotterdam Study. Eur J Epidemiol 
2007;22:763-70.
38. Larsson SK, Virtanen MJ, Mars M, Mannisto S, Piet-
innen P, Albanes D. Magnesium, Calcium, Potassium 
and Sodium intakes and risk of stroke in male smok-
ers. Arch Intern Med 2008;168:459-65.
39. Fontana L. The scientific basis of caloric restriction 
leading to longer life. Curr Opin Gastrenterol 2009; 
25:144-50.
40. Dirks AJ, Leeuvenburgh C. Caloric restriction in hu-
mans: potential pitfalls and health concerns. Mech 
Ageing Dev 2006;127:1-7.
41. Joffres MR, Reed DM, Yano K. Relationship of mag-
nesium intake and other dietary factors to blood pres-
sure: the Honolulu heart study. Am J Clin Nutr 1987; 
45:469-75.
42. Jee SH, Miller ER 3rd ,Guallar E, Singh VK, Appel 
LJ Klag MJ. The effect of magnesium supplementa-
tion on blood pressure: a meta-analysis of randomized 
clinical trials. Am J Hypertens 2002;15:691-6.
43. Barkley GS. Factors influencing health behaviors 
in the National Health and Nutritional Examination 
Survey, III (NHANES III). Soc Health Care 2008; 
46:57-79.
44. Dickinson HO, Nicolson DJ, Campbell F, Cook JV, 
Beyer FR, Ford GA et al. Magnesium supplementa-
tion for the management of essential hypertension in 
adults. Cochrane Database Syst Rev 2006;19:3.
45. Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knut-
son M, Koraym A et al. Health benefits of dietary fiber. 
Nutr Rev 2009;67:188-205.
46. Trumbo PR, Ellwood KC. Supplemental calcium a 
risk reduction of hypertension, pregnancy-induced 
hypertension, and preeclampsia: an evidence-based 
review by the US Food and Drug Administration. Nutr 
Rev 2007;65:78-87.
47. Miller GD, Jarvis JK, McBean LD. The importance 
of meeting calcium needs with foods. J Am Coll Nutr 
2001;20:168-185.
48. Kris-Etherton PM, Grieger JA, Hilpert KF, West SG. 
Milk products, dietary patterns and blood pressure 
management. J Am Coll Nutr 2009;1:103-19.
49. Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur 
A. High fructose consumption combined with low di-
etary magnesium intake may increase the incidence 
of a metabolic syndrome by inducing inflammation. 
Magnes Res 2006;19:237-43.
50. Hu FB, Willett WC, Optimal diets for prevention of 
coronary heart disease. JAMA 2002;288:2569-78.
51. Phillips C, Lopez-Miranda J, Perez-Jimenez F, Mc-
Manus R, Roche HM. Genetic and nutritional deter-
minants of the metabolic syndrome. Curr Opin Cardiol 
2006;21:185-93.
52. Sharma N, Okere IC, Duda MK, Chess DJ, O’Shea 
KM, Stantley WC. Potential impact of carbohydrate 
and fat intake on pathological left ventricular hyper-
trophy. Cardiovasc Res 2007;73:257-68.
53. Mozaffarian D. Effects of dietary fats versus carbohy-
drates on coronary heart disease: a review of the evi-
dence. Curr Atheroscler Rep 2005;7:435-45.
54. Sirtori CR, Galli C, Anderson JW, Arnoldi A. Nutri-
tional and nutraceutical approaches to dyslipidemia 
and atherosclerosis prevention: Focus on dietary pro-
teins. Atherosclerosis 2009;203:8-17.
55. Loizzo MR, Tundis R, Menichini F, Statti GA. Hy-
potensive natural products: current status. Mini Rev 
Med Chem 2008;8:828-55.
